Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2020Cited by 61
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcareDaniele Donà, Olivia Boyer, Dominque Debray et al.|Clinical Transplantation|2020Cited by 50
Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group SurveyAlastair Baker, Paloma Jara, Esteban Frauca Remacha et al.|Children|2021Cited by 37
European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guidelineIsmay A E de Beijer, Paulius Ragauskas, Roderick Skinner et al.|Journal of Cancer Survivorship|2023Cited by 14
Cross-cutting view of current challenges in paediatric solid organ and haematopoietic stem cell transplantation in Europe: the European Reference Network TransplantChildLinda Wennberg, Pedro Jara, A J Baker et al.|Orphanet Journal of Rare Diseases|2020Cited by 13